(Q41432878)

30 September 2017

1 reference

title

Measurements of leukotrienes in the urine: strategies and applications (English)

1 reference

30 September 2017

Kumlin M

1

1 reference

30 September 2017

publication date

1 February 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

52

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

124-135

1 reference

Sulphidopeptide leukotrienes in asthma

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Characteristics of formation and further metabolism of leukotrienes in the chopped human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Release of leukotrienes in patients with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.1997.TB00966.X

10.1111/J.1398-9995.1997.TB00966.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference